Mary Kay Fenton
2022 - Tourmaline Bio
In 2022, Mary Kay Fenton earned a total compensation of $2.2M as Former Interim Chief Executive Officer and President and Chief Financial Officer at Tourmaline Bio.
Compensation breakdown
| Non-Equity Incentive Plan | $131,783 |
|---|---|
| Option Awards | $1,301,440 |
| Salary | $455,000 |
| Stock Awards | $308,800 |
| Other | $12,200 |
| Total | $2,209,223 |
Fenton received $1.3M in option awards, accounting for 59% of the total pay in 2022.
Fenton also received $131.8K in non-equity incentive plan, $455K in salary, $308.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Mary Kay Fenton's compensation ranked 1,624th out of 5,676 executives tracked by ExecPay. In other words, Fenton earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,624 out of 5,676 | 71st |
Division Manufacturing | 832 out of 3,084 | 73rd |
Major group Chemicals And Allied Products | 326 out of 1,399 | 77th |
Industry group Drugs | 302 out of 1,300 | 77th |
Industry Biological Products, Except Diagnostic Substances | 75 out of 295 | 75th |
Source: SEC filing on April 19, 2024.
Fenton's colleagues
We found two more compensation records of executives who worked with Mary Kay Fenton at Tourmaline Bio in 2022.